Persistence of antibody to hepatitis B surface antigen [PDF]
Journal of Clinical Microbiology, 1976Sera from military personnel found to have antibodies to hepatitis B surface antigen (anti-HBS) in an epidemiological study of a hepatitis B outbreak were tested for persistence of that antibody 1 year later. Initially, 64% of the anti-HBS-positive sera reacted in passive hemagglutination tests with erythrocytes coated with hepatitis B surface antigen ...
Gilbert R. Irwin+5 more
openalex +4 more sources
Hepatitis Delta Virus: A Peculiar Virus [PDF]
Advances in Virology, 2013The hepatitis delta virus (HDV) is distributed worldwide and related to the most severe form of viral hepatitis. HDV is a satellite RNA virus dependent on hepatitis B surface antigens to assemble its envelope and thus form new virions and propagate ...
Carolina Alves+2 more
doaj +2 more sources
Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients [PDF]
Virology Journal, 2011Background The understanding of the distribution of hepatitis B virus genotypes and the occult hepatitis B virus infection in hepatocellular carcinoma may shed light into the prevention and treatment of hepatocellular carcinoma.
Liang Ping+7 more
doaj +5 more sources
Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients [PDF]
Vojnosanitetski Pregled, 2023Background/Aim. Quantitative hepatitis B virus (HBV) surface antigen (qHBsAg) has become increasingly wide-spread in the last few years in both diagnostic and therapeutic protocols for HBV infection.
Pete Maria+5 more
doaj +1 more source
Prevalence of hepatitis B in dental patients
Journal of Indian Academy of Oral Medicine and Radiology, 2023Background: Hepatitis B virus (HBV) infection is one of the leading causes of death worldwide. The most important marker for HBV infection is HBsAg. In case of diagnosis of infectious disease, discordant results may have serious consequences among the ...
Ashmita Kaur R. Chawla+2 more
doaj +1 more source
Proteins of hepatitis B surface antigen [PDF]
Journal of Virology, 1977Purified 22-nm forms of hepatitis B surface antigen (Hbsag) representing the three major antigenic subtypes (adw, ayw, and adr) were analyzed for their constituent polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. No consistent difference in either the number or relative distributions of the polypeptides was observed for the ...
J. L. Gerin, J. W. K. Shih
openaire +3 more sources
Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence [PDF]
Journal of Pathology and Translational Medicine, 2016Background: Hepatitis B virus (HBV) plays well-known roles in tumorigenesis of hepatocellular carcinoma (HCC) in infected patients. However, HBV-associated protein status in tumor tissues and the relevance to tumor behavior has not been reported.
Jing Jin+6 more
doaj +1 more source
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm [PDF]
Clinical and Molecular Hepatology, 2023Nucleos(t)ide analogues (NA) are widely used to treat hepatitis B virus (HBV) infection, but they cannot eradicate the virus and treatment duration can be lifelong if the endpoint is set at seroclearance of the hepatitis B surface antigen (HBsAg).
Yao-Chun Hsu+2 more
doaj +1 more source
ARC‐520, the first an RNA interference (RNAi) therapeutic, was designed to reduce all RNA transcripts derived from covalently closed circular DNA, leading to a reduction in viral antigens and hepatitis B virus (HBV) DNA.
M. Yuen+17 more
semanticscholar +1 more source
Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance [PDF]
Clinical and Molecular Hepatology, 2021Background/Aims The role of hepatitis B virus (HBV) integration into the host genome in hepatocarcinogenesis following hepatitis B surface antigen (HBsAg) seroclearance remains unknown.
Jeong Won Jang+9 more
doaj +1 more source